28398095|t|Influence of drug load on dissolution behavior of tablets containing a poorly water - soluble drug: estimation of the percolation threshold
28398095|a|Drug load plays an important role in the development of solid dosage forms, since it can significantly influence both processability and final product properties. The percolation threshold of the active pharmaceutical ingredient (API) corresponds to a critical concentration, above which an abrupt change in drug product characteristics can occur. The objective of this study was to identify the percolation threshold of a poorly water - soluble drug with regard to the dissolution behavior from immediate release tablets. The influence of the API particle size on the percolation threshold was also studied. Formulations with increasing drug loads were manufactured via roll compaction using constant process parameters and subsequent tableting. Drug dissolution was investigated in biorelevant medium. The percolation threshold was estimated via a model dependent and a model independent method based on the dissolution data. The intragranular concentration of mefenamic acid had a significant effect on granules and tablet characteristics, such as particle size distribution, compactibility and tablet disintegration. Increasing the intragranular drug concentration of the tablets resulted in lower dissolution rates. A percolation threshold of approximately 20% v/v could be determined for both particle sizes of the API above which an abrupt decrease of the dissolution rate occurred. However, the increasing drug load had a more pronounced effect on dissolution rate of tablets containing the micronized API, which can be attributed to the high agglomeration tendency of micronized substances during manufacturing steps, such as roll compaction and tableting. Both methods that were applied for the estimation of percolation threshold provided comparable values.
28398095	0	9	Influence	T077	C4054723
28398095	13	17	drug	T121	C1254351
28398095	18	22	load	T081	C0392762
28398095	26	46	dissolution behavior	T070	C3850077
28398095	50	57	tablets	T122	C0039225
28398095	71	77	poorly	T080	C0542537
28398095	78	83	water	T121,T197	C0043047
28398095	86	93	soluble	T080	C1948047
28398095	94	98	drug	T121	C1254351
28398095	100	110	estimation	T081	C0750572
28398095	118	129	percolation	T067	C1254366
28398095	130	139	threshold	T080	C0449864
28398095	140	144	Drug	T121	C1254351
28398095	145	149	load	T081	C0392762
28398095	159	168	important	T080	C3898777
28398095	181	192	development	T169	C1527148
28398095	196	214	solid dosage forms	T122	C1378566
28398095	243	252	influence	T077	C4054723
28398095	258	272	processability	T052	C1709694
28398095	277	282	final	T079	C3853528
28398095	283	290	product	T071	C1514468
28398095	291	301	properties	T080	C0871161
28398095	307	318	percolation	T067	C1254366
28398095	319	328	threshold	T080	C0449864
28398095	336	368	active pharmaceutical ingredient	T120	C1372955
28398095	370	373	API	T120	C1372955
28398095	392	414	critical concentration	T081	C2348011
28398095	431	444	abrupt change	T080	C1276802
28398095	448	452	drug	T121	C1254351
28398095	453	460	product	T071	C1514468
28398095	461	476	characteristics	T080	C1521970
28398095	492	501	objective	T170	C0018017
28398095	510	515	study	T062	C2603343
28398095	536	547	percolation	T067	C1254366
28398095	548	557	threshold	T080	C0449864
28398095	563	569	poorly	T080	C0542537
28398095	570	575	water	T121,T197	C0043047
28398095	578	585	soluble	T080	C1948047
28398095	586	590	drug	T121	C1254351
28398095	610	630	dissolution behavior	T070	C3850077
28398095	636	645	immediate	T079	C0205253
28398095	646	653	release	T169	C0391871
28398095	654	661	tablets	T122	C0039225
28398095	667	676	influence	T077	C4054723
28398095	684	687	API	T120	C1372955
28398095	688	701	particle size	T081	C0030608
28398095	709	720	percolation	T067	C1254366
28398095	721	730	threshold	T080	C0449864
28398095	749	761	Formulations	T062	C0524527
28398095	767	777	increasing	T169	C0442808
28398095	778	782	drug	T121	C1254351
28398095	783	788	loads	T081	C0392762
28398095	794	806	manufactured	T057	C0870840
28398095	811	826	roll compaction	T059	C3830384
28398095	833	841	constant	T080	C1948059
28398095	842	849	process	T067	C1522240
28398095	850	860	parameters	T077	C0549193
28398095	865	875	subsequent	T079	C0332282
28398095	876	885	tableting	T122	C0039225
28398095	887	903	Drug dissolution	T070	C3850077
28398095	908	920	investigated	T169	C1292732
28398095	924	942	biorelevant medium	T167	C1705217
28398095	948	959	percolation	T067	C1254366
28398095	960	969	threshold	T080	C0449864
28398095	990	995	model	T075	C0026336
28398095	996	1005	dependent	T080	C0851827
28398095	1012	1017	model	T075	C0026336
28398095	1018	1029	independent	T078	C0085862
28398095	1030	1036	method	T059	C0871511
28398095	1050	1061	dissolution	T070	C3850077
28398095	1062	1066	data	T078	C1511726
28398095	1086	1099	concentration	T081	C0678756
28398095	1103	1117	mefenamic acid	T109,T121	C0025152
28398095	1124	1135	significant	T078	C0750502
28398095	1136	1142	effect	T080	C1280500
28398095	1146	1154	granules	T122	C3853573
28398095	1159	1165	tablet	T122	C0039225
28398095	1166	1181	characteristics	T080	C1521970
28398095	1191	1204	particle size	T081	C0030608
28398095	1205	1217	distribution	T169	C1704711
28398095	1219	1233	compactibility	T080	C0205556
28398095	1238	1259	tablet disintegration	T122	C0991504
28398095	1261	1271	Increasing	T169	C0442808
28398095	1290	1308	drug concentration	T081	C0678756
28398095	1316	1323	tablets	T122	C0039225
28398095	1324	1332	resulted	T169	C1274040
28398095	1342	1353	dissolution	T070	C3850077
28398095	1354	1359	rates	T081	C1521828
28398095	1363	1374	percolation	T067	C1254366
28398095	1375	1384	threshold	T080	C0449864
28398095	1388	1401	approximately	T080	C0332232
28398095	1439	1453	particle sizes	T081	C0030608
28398095	1461	1464	API	T120	C1372955
28398095	1480	1486	abrupt	T080	C1276802
28398095	1487	1495	decrease	T081	C0547047
28398095	1503	1514	dissolution	T070	C3850077
28398095	1515	1519	rate	T081	C1521828
28398095	1520	1528	occurred	T052	C1709305
28398095	1543	1553	increasing	T169	C0442808
28398095	1554	1558	drug	T121	C1254351
28398095	1559	1563	load	T081	C0392762
28398095	1586	1592	effect	T080	C1280500
28398095	1596	1607	dissolution	T070	C3850077
28398095	1608	1612	rate	T081	C1521828
28398095	1616	1623	tablets	T122	C0039225
28398095	1639	1649	micronized	T059	C3829074
28398095	1650	1653	API	T120	C1372955
28398095	1686	1690	high	T080	C0205250
28398095	1691	1704	agglomeration	T080	C0205387
28398095	1717	1727	micronized	T059	C3829074
28398095	1728	1738	substances	T167	C0439861
28398095	1746	1765	manufacturing steps	T077	C1261552
28398095	1775	1790	roll compaction	T059	C3830384
28398095	1795	1804	tableting	T122	C0039225
28398095	1811	1818	methods	T059	C0871511
28398095	1845	1855	estimation	T081	C0750572
28398095	1859	1870	percolation	T067	C1254366
28398095	1871	1880	threshold	T080	C0449864
28398095	1890	1900	comparable	T052	C1707455
28398095	1901	1907	values	T081	C1522609